C18orf16, or Chromosome 18 Open Reading Frame 16, is a gene located on the 18th chromosome in humans. Its precise locus is defined as 18q21.2, which means it is situated on the long arm of chromosome 18 in region 2, band 1, sub-band 2. The protein encoded by the C18orf16 gene is a member of the human proteome, but as with many open reading frames identified through genome sequencing projects, it may be relatively uncharacterized in terms of its biological functions and interactions.Research into C18orf16 and its encoded protein has yet to fully uncover its roles within cellular processes. However, the designation "orf" suggests that the region was initially identified as part of genomic annotation efforts and may have been recognized due to its potential to encode a protein based on its sequence motifs and predicted structure rather than through empirical protein function characterization.
The C18orf16 protein could be involved in a variety of cellular activities, ranging from regulation of gene expression, protein-protein interactions, metabolic processes, or even cell signaling pathways. As with many proteins of uncertain function, it may interact with other proteins or cellular components, and these interactions can help to elucidate its role in cellular physiology.Further experimental studies, including gene expression analysis, protein interaction assays, and functional characterization studies, are needed to reveal the significance of C18orf16 in human biology. Its expression pattern across tissues, response to different cellular stimuli, and potential involvement in disease states or developmental processes remain areas of active investigation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), which could affect pathways that C18orf16 is involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor, which may indirectly influence C18orf16-related pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, a key kinase in many signaling pathways, potentially impacting C18orf16's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Targets p38 MAP kinase, potentially affecting pathways involving C18orf16. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A selective inhibitor of MEK, which may indirectly influence C18orf16 function through MAPK signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which may alter pathways connected to C18orf16. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $94.00 $348.00 | 69 | |
Inhibits BMP signaling, which could be relevant to C18orf16's pathway interactions. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor, potentially affecting cytoskeletal dynamics related to C18orf16. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
A V-ATPase inhibitor, which could indirectly affect C18orf16's cellular context. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
An ER stress inducer, potentially influencing C18orf16-related pathways. | ||||||